Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Symlin
Symlin
AstraZeneca's New Diabetes Drug May Also Combat Alzheimer's Disease
Seeking Alpha
Thu, 03/27/14 - 05:00 pm
diabetes
Alzheimer's disease
AstraZeneca
Symlin
Symlin Use Helped Patients with Type 2 or Type 1 Diabetes Achieve More Time in Normal Glucose Range
Yahoo/Business Wire
Sat, 06/9/12 - 12:38 pm
Symlin
type 2 diabetes
diabetes
type 1 diabetes
Amylin
Analysis Provides New Insights Into Use of Symlin in Patients With Type 1 Diabetes Using Insulin Pumps
Yahoo/PR NewsWire
Sat, 06/25/11 - 10:41 am
Symlin
insulin pumps
diabetes
Amylin
Meta-Analysis of SYMLIN(R) Clinical Data Showed No Increased Risk of Cardiovascular Adverse Events Associated With SYMLIN Treatment in Patients With Type 2 Diabetes
Yahoo/PR NewsWire
Sun, 06/27/10 - 10:54 am
Symlin
Amylin
diabetes
type 1 diabetes